Keywords:
expert interviews, oncology, cancer, clinical trials, supportive care, FDA Approvals, i3 health, asco cap her2 guidelines 2018, asco her2 guidelines 2018, trastuzumab duocarmazine
| Created: | 2023-03-21 |
| Expires: | 2024-03-21 |
| Owner: | Eszter Hazai (Domain Science Ltd) |
| Hosting company: | Bodis, LLC |
| IPs: | 199.59.243.225 |
| DNS: |
ns1.bodis.com ns2.bodis.com |
| Email: | See owner's emails |
